SBIR/STTR Research Award
Quantitative Test of the Success/Reduction of Harm of Smoking Cessation Treatment
Award amount
$202,167Program and phase
SBIR · Phase IAward year
2014Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- BEHAVIORAL DIAGNOSTICS, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- C8DQNL9C97V8
- Solicitation number
- PA13-234
- Topic code
- NIDA
Research abstract
DESCRIPTION (provided by applicant): Cigarette smoking is the most common preventable cause of morbidity and mortality in the United States. Over the past 20 years, several effective treatments, including varenicline, bupropion and nicotine replacement treatments (NRT, such as nicotine gum or patches) have been developed. Despite significant efforts, the overall success of these treatments for smoking cessation is about 10%. Although there are number of potential barriers to increasing the success rate ofthese treatments, one of the most vexing is the lack of methods to objectively quantify treatment success/reduction of harm and provide evidence-based positive feedback to patients. Developing, validating, and commercializing this next-generation technology to exactly quantify the amount of smoking cessation success/harm reduction is Behavioral Diagnostic's overall goal for this multi-phase SBIR study. Currently, two biomarkers of smoking- exhaled carbon monoxide (CO) and (serum, salivary or urinary)
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- A Test for Heavy Alcohol Consumption in First Episode Coronary Heart Disease
- An Improved Epigenetic Algorithm for Guiding Low Dose CT Lung Cancer Screening
- A Saliva Based Epigenetic Assay for Assessing Vitamin B9 and B12 Status
- A DNA Methylation Test for Guiding Lung Cancer Screening
- Quantitative Biomarkers for Monitoring Alcohol Abstinence
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)
Research funding history
11 SBIR/STTR records share this UEI (2013–2025). Reported award amounts total $6,629,540. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services